Existing processes used for developing stable cell lines for the production of biotherapeutics or identifying new antibody targets are not only time consuming but also inefficient. Regardless of ...

Cyto-Mine Chroma represents the next generation of Sphere Fluidics’ industry-leading Cyto-Mine single-cell analysis platform. The Early Access Program provides an opportunity to be among the ...

Providing ultra-high-throughput screening of single cell assays and antibody-producing cells as well as the ability to sort them, Cyto-Mine is ready for use. Sphere Fluidics has now successfully ...

Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D Cyto-Mine Chroma ...